Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide Soft Capsule for Vascular Dementia
NCT03804229Phase 3Active, not recruiting
- Sponsor
- Capital Medical University
- Start
- Oct 2019
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butylphthalide in vascular dementia, sponsored by Capital Medical University. Started Oct 2019; status: active, not recruiting.
02
Drugs
butylphthalide
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT03804229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804229.